Effects of cannabinoid receptor type 2 in respiratory syncytial virus infection in human subjects and mice. Issue 1 (1st January 2018)

• Record Type: Journal Article
• Authors: Tahamtan, Alireza; Samieipoor, Yazdan; Nayeri, Fatemeh Sadat; Rahbarimanesh, Ali Akbar; Izadi, Anahita; Rashidi-Nezhad, Ali; Tavakoli-Yaraki, Masoumeh; Farahmand, Mohammad; Bont, Louis; Shokri, Fazel; Mokhatri-Azad, Talat; Salimi, Vahid
• Is Part Of: Virulence. Volume 9:Issue 1(2018)
• Page Start: 217
• Page End: 230
• Publication Date: 2018-01-01
• Subjects: Acute respiratory tract infection -- CB2 receptors -- single nucleotide polymorphism -- immunomodulation -- Respiratory syncytial virus -- respiratory viral infection; Virulence (Microbiology) -- Periodicals; Bacterial diseases -- Periodicals; Molecular microbiology -- Periodicals; 579.05
• DOI: 10.1080/21505594.2017.1389369
• Languages: English
• ISSNs: 2150-5608

Abstract

ABSTRACT: An accumulating body of evidence suggests that the endocannabinoid system plays a significant role in pathophysiological processes and impacts disease severity. Here we investigate the possible role of a cannabinoid receptor type 2 (CB2) functional variant in determining disease severity and the potential pharmacological therapeutic effects of CB2 activation in viral respiratory infection. The common missense variant (CAA/CGG; Q63R) of the gene-encoding CB2 receptor (CNR2) was evaluated in 90 inpatient and 90 outpatient children with acute respiratory tract infection (ARTI). The frequency distribution of respiratory syncytial virus (RSV)-the main cause of severe cases of bronchiolitis and pneumonia in children-was studied in all collected samples. The mechanism through which CB2 affects clinical outcomes in case of RSV infection was studied in Balb/c mice model using AM630 as a CB2 antagonist. The potential therapeutic effect of CB2 activation during RSV infection was studied using a selective agonist, JWH133. The CB2 Q63R variation was associated with increased risk of hospitalization in children with ARTI. Children carrying the QQ genotype were more prone to developing severe ARTI (OR = 3.275, 95% CI: 1.221–8.705; p = 0.019). Of all the children enrolled in the study, 83 patients (46.1%) were found positive for RSV infection. The associated risk of developing severe ARTI following RSV infection increased more than two-fold in children carrying the Q allele (OR = 2.148, 95% CI: 1.092–4.224; p = 0.026). In mice, the blockade of CB2 by AM630 during RSV infection enhanced the influx of BAL cells and production of cytokines/chemokines while exaggerating lung pathology. CB2 activation by JWH133 reduces the influx of BAL cells and production of cytokines/chemokines while alleviating lung pathology. Collectively, CB2 is associated with RSV severity during infancy and may serve as a therapeutic target in RSV infection through the alleviation of virus-associated immunopathology.